NIH-funded research R01 grant

Investigating how certain proteins interact to regulate cell signaling

Official title: Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions

Funded at Lehigh University · NIH-10797721 · Data updated 2026-11-12

This study is looking at special proteins that help control how cells communicate, with the goal of finding new treatments for cancer by understanding how these proteins work together.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLehigh University
NIH-funded
Lab location1 site (Bethlehem, United States)
Project startSeptember 20, 2020
Project endJune 30, 2025
Funding year2023
Award (this year)$90,505
NIH project number3R01GM139998-04S1
Project IDNIH-10797721 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with cancers that involve dysregulated receptor tyrosine kinases.

Less likely to help

Patients with conditions unrelated to receptor tyrosine kinase signaling may not benefit from this research.

What this research studies

This research focuses on receptor protein tyrosine phosphatases (RPTPs), which are crucial for regulating cell signaling in health and disease. The study aims to understand how the interactions between these proteins affect their activity and how this knowledge can be used to develop new therapies. By examining the molecular mechanisms that control RPTP interactions, the researchers hope to find ways to enhance their function against cancer-related signaling pathways. Patients may benefit from potential new treatments that target these interactions to improve health outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating cancers by enhancing the activity of specific proteins involved in cell signaling.

How similar studies have gone: While the specific approach of targeting transmembrane domain interactions is novel, similar research has shown promise in enhancing protein function in other contexts.

Where this research is happening

  • Lehigh University
    Bethlehem, United States
    Active

Researchers

  • Principal investigator: Thevenin, Damien — Lehigh University
  • Study coordinator: Thevenin, Damien

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.